CoChat
Sign Up
Cited by 71

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Unbiased Gene Expression Analysis Implicates the huntingtin Polyglutamine Tract in Extra-mitochondrial Energy Metabolism

Lee, Jong-Min, Ivanova, Elena V, Seong, Ihn Sik, Cashorali, Tanya, Kohane, Isaac, Gusella, James F, MacDonald, Marcy E·2007·PLoS Genetics
DOI 10.1371/journal.pgen.0030135PMC PMC1950164
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.0030135

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 51

  1. The Huntington's Disease Collaborative Research Group, 1993, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes., Cell, 72, 971, 10.1016/0092-8674(93)90585-E · DOI · Paper page
  2. 1985, Neuropathological classification of Huntington's disease., J Neuropathol Exp Neurol, 44, 559, 10.1097/00005072-198511000-00003 · DOI · Paper page
  3. 1997, 3-Nitropropionic acid animal model and Huntington's disease., Neurosci Biobehav Rev, 21, 289, 10.1016/S0149-7634(96)00027-9 · DOI
  4. 1982, Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan., Ann Neurol, 12, 425, 10.1002/ana.410120504 · DOI · Paper page
  5. 1987, Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease., N Engl J Med, 316, 357, 10.1056/NEJM198702123160701 · DOI
  6. 1990, A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease., Ann Neurol, 28, 614, 10.1002/ana.410280503 · DOI
  7. 1993, Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy., Neurology, 43, 2689, 10.1212/WNL.43.12.2689 · DOI
  8. 1998, 1H NMR spectroscopy studies of Huntington's disease: Correlations with CAG repeat numbers., Neurology, 50, 1357, 10.1212/WNL.50.5.1357 · DOI
  9. 2000, Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy., Ann Neurol, 48, 72, 10.1002/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I · DOI
  10. 2005, Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease., Mov Disord, 20, 674, 10.1002/mds.20373 · DOI
  11. 2005, HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism., Hum Mol Genet, 14, 2871, 10.1093/hmg/ddi319 · DOI
  12. 2006, Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral/motor phenotypes in vivo and elevated levels of ATP with cellular senescence in vitro., Hum Mol Genet, 15, 607, 10.1093/hmg/ddi477 · DOI
  13. 2003, In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease., Arch Biochem Biophys, 410, 1, 10.1016/S0003-9861(02)00585-4 · DOI
  14. 2000, Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells., Hum Mol Genet, 9, 2799, 10.1093/hmg/9.19.2799 · DOI
  15. 2006, Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration., Cell, 127, 59, 10.1016/j.cell.2006.09.015 · DOI · Paper page
  16. 2006, Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration., Cell Metab, 4, 349, 10.1016/j.cmet.2006.10.004 · DOI · Paper page
  17. 2005, Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin., J Biol Chem, 280, 30773, 10.1074/jbc.M504749200 · DOI
  18. 2003, Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice., Hum Mol Genet, 12, 497, 10.1093/hmg/ddg046 · DOI
  19. 2006, Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells., Eur J Neurosci, 23, 1701, 10.1111/j.1460-9568.2006.04686.x · DOI
  20. 2003, Influence of cytosolic and mitochondrial Ca2+, ATP, mitochondrial membrane potential, and calpain activity on the mechanism of neuron death induced by 3-nitropropionic acid., Neurochem Int, 43, 89, 10.1016/S0197-0186(02)00229-2 · DOI
  21. 2005, Discovering statistically significant pathways in expression profiling studies., Proc Natl Acad Sci U S A, 102, 13544, 10.1073/pnas.0506577102 · DOI
  22. 2002, Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses., Hum Mol Genet, 11, 1953, 10.1093/hmg/11.17.1953 · DOI · Paper page
  23. 2004, Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway., Nat Cell Biol, 6, 45, 10.1038/ncb1080 · DOI
  24. 2006, Systematic identification of human mitochondrial disease genes through integrative genomics., Nat Genet, 38, 576, 10.1038/ng1776 · DOI
  25. 2006, Regional and cellular gene expression changes in human Huntington's disease brain., Hum Mol Genet, 15, 965, 10.1093/hmg/ddl013 · DOI · Paper page
  26. 1997, Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion., Nat Genet, 17, 404, 10.1038/ng1297-404 · DOI
  27. 2003, Wild-type huntingtin plays a role in brain development and neuronal survival., Mol Neurobiol, 28, 259, 10.1385/MN:28:3:259 · DOI
  28. 2006, Body weight is modulated by levels of full-length huntingtin., Hum Mol Genet, 15, 1513, 10.1093/hmg/ddl072 · DOI
  29. 2005, Inactivation of the Huntington's disease gene (Hdh) impairs anterior streak formation and early patterning of the mouse embryo., BMC Dev Biol, 5, 17, 10.1186/1471-213X-5-17 · DOI
  30. 1998, Mouse mutant embryos lacking huntingtin are rescued from lethality by wild-type extraembryonic tissues., Development, 125, 1529, 10.1242/dev.125.8.1529 · DOI
  31. 2000, Huntingtin: An iron-regulated protein essential for normal nuclear and perinuclear organelles., Hum Mol Genet, 9, 2789, 10.1093/hmg/9.19.2789 · DOI · Paper page
  32. 2003, Huntingtin: Alive and well and working in middle management., Sci STKE, 2003, pe48
  33. 2003, Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes., Nat Genet, 35, 76, 10.1038/ng1219 · DOI · Paper page
  34. 2004, NFY interacts with the promoter region of two genes involved in the rat peroxisomal fatty acid beta-oxidation: the multifunctional protein type 1 and the 3-ketoacyl-CoA B thiolase., Lipids Health Dis, 3, 4, 10.1186/1476-511X-3-4 · DOI
  35. 2006, Redox regulation in anabolic and catabolic processes., Curr Opin Clin Nutr Metab Care, 9, 190, 10.1097/01.mco.0000222098.98514.40 · DOI
  36. 2006, Activation of glutathione peroxidase via Nrf1 mediates genistein's protection against oxidative endothelial cell injury., Biochem Biophys Res Commun, 346, 851, 10.1016/j.bbrc.2006.05.197 · DOI
  37. 2002, Interaction of Huntington disease protein with transcriptional activator Sp1., Mol Cell Biol, 22, 1277, 10.1128/MCB.22.5.1277-1287.2002 · DOI
  38. 2005, In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets., Cell, 123, 1241, 10.1016/j.cell.2005.10.030 · DOI
  39. 2006, Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease., Neurobiol Dis, 22, 233, 10.1016/j.nbd.2005.11.001 · DOI
  40. 2002, The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor., BMC Neurosci, 3, 15, 10.1186/1471-2202-3-15 · DOI
  41. 1992, Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62., Nucleic Acids Res, 20, 3821, 10.1093/nar/20.15.3821 · DOI
  42. 2006, Buffering mitochondrial DNA variation., Nat Genet, 38, 1232, 10.1038/ng1106-1232 · DOI
  43. 2002, Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD., J Appl Physiol, 92, 1205, 10.1152/japplphysiol.00116.2001 · DOI
  44. 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method., Methods, 25, 402, 10.1006/meth.2001.1262 · DOI · Paper page
  45. 2003, A comparison of normalization methods for high density oligonucleotide array data based on variance and bias., Bioinformatics, 19, 185, 10.1093/bioinformatics/19.2.185 · DOI
  46. 2003, Statistical significance for genomewide studies., Proc Natl Acad Sci U S A, 100, 9440, 10.1073/pnas.1530509100 · DOI · Paper page
  47. 2003, DAVID: Database for annotation, visualization, and integrated discovery., Genome Biol, 4, P3, 10.1186/gb-2003-4-5-p3 · DOI · Paper page
  48. 1998, Cluster analysis and display of genome-wide expression patterns., Proc Natl Acad Sci U S A, 95, 14863, 10.1073/pnas.95.25.14863 · DOI · Paper page
  49. 2001, Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection., Proc Natl Acad Sci U S A, 98, 31, 10.1073/pnas.98.1.31 · DOI · Paper page
  50. 2004, Bioconductor: open software development for computational biology and bioinformatics., Genome Biol, 5, R80, 10.1186/gb-2004-5-10-r80 · DOI
  51. 2005, The MAPPER database: A multi-genome catalog of putative transcription factor binding sites., Nucleic Acids Res, 33, D91

Cited by

Sorted by citations

Metadata

Authors
Lee, J.-M., Ivanova, E. V., Seong, I. S., Cashorali, T., Kohane, I., Gusella, J. F., & MacDonald, M. E.
Venue
PLoS Genetics
Publisher
Public Library of Science (PLoS)
Published
2007-08-17
Volume
3
Issue
8
Pages
e135
ISSN
1553-7404
DOI
10.1371/journal.pgen.0030135
PMC
PMC1950164
Cited by
71
References
5
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review